pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Eli Lilly and Co

updated 5mo ago

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.

community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval150 co-mentions · 75 sources
  • drugMOUNJARO48 co-mentions · 24 sources
  • drugZEPBOUND48 co-mentions · 24 sources
  • drugtirzepatide48 co-mentions · 24 sources
  • drugTRULICITY44 co-mentions · 22 sources
  • drugdulaglutide44 co-mentions · 22 sources
  • drugselpercatinib38 co-mentions · 19 sources
  • drugRETEVMO38 co-mentions · 19 sources
pipeline
28
marketed
18
phase 3
4
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(28)

view full pipeline →
pipeline depth28 products
Phase 2: 4Phase 3: 4Marketed: 18pre_registration: 2
4Phase 24Phase 318Marketed2pre_registration
Marketed
Abasaglar
Type 1 Diabetes (Juvenile Diabetes)
Marketed
Adcirca
Pulmonary Arterial Hypertension
Marketed
Lyumjev
Type 1 Diabetes (Juvenile Diabetes)
Marketed
Prozac
Depression
Marketed
abemaciclib
Human Epidermal Growth Factor Receptor 2 Negative Breast…
Marketed
baricitinib
Alopecia Areata
Tyrosine-protein kinase JAK1Tyrosine-protein kinase JAK2
Marketed
donanemab
Alzheimer's Disease
Marketed
dulaglutide
Cardiovascular Risk Factors
Marketed
etesevimab
Coronavirus Disease 2019 (COVID-19)
Marketed
galcanezumab
Migraine
Marketed
imlunestrant tosylate
Human Epidermal Growth Factor Receptor 2 Negative Breast…
Marketed
ixekizumab
Plaque Psoriasis (Psoriasis Vulgaris)

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view Eli Lilly and Co jobs →

News

  • As part of sales reorganization, Novo will cut 215 employees at US HQ
    Follow along as BioSpace tracks job cuts and restructuring initiatives.
    biospace · 1d ago
  • Celldex drug stumbles in eczema; Epigenetic editing startup cuts staff
    Wall Street analysts rushed to Celldex’s defense following the setback. Elsewhere, Isomorphic Labs cut a cancer-focused deal with Merck and Teva’s research chief accepted a new job.
    biopharma_dive · 1d ago
  • FDA publishes rejection letter for Summit drug; Nuvalent buyout pays more dividends for GSK
    The FDA had several issues with ivonescimab, according to the letter. Elsewhere, Sellas shares rocketed on results for a leukemia vaccine and Biogen and Lilly struck up new R&D pacts.
    biopharma_dive · 3d ago
  • 8 companies hiring in North Carolina now
    Looking for a biopharma role in North Carolina? Jobs on BioSpace increased significantly year over year in October. Check out the open positions posted now for life sciences professionals like you.
    biospace · 3d ago
  • Summit’s rejection, Isomorphic’s record $5B raise, obesity and Alzheimer’s in the spotlight
    The FDA declined to approve Summit Therapeutics’ Akeso-partnered ivonescimab, putting other PD-1/VEGF drug developers on notice; Isomorphic bagged a $5 billion series C, the largest in biotech hist…
    biospace · 3d ago
  • Isomorphic Labs breaks biotech VC fundraising record with $5B series C
    After securing $2.1 billion this May, AI-driven drug designer Isomorphic Labs is back with more money—a lot more—securing the industry’s largest private fundraise ever.
    biospace · 4d ago
  • AI drugmaker Isomorphic restocks with $5B fundraise
    Even as the larger AI industry faces turmoil, investors have given Isomorphic the two largest cash infusions in the biotech sector this year.
    biopharma_dive · 4d ago
  • Lilly pens another deal, inking up to $5.9B oncology pact with Stipple
    A licensing pact with Stipple Bio was one of two announced by Eli Lilly on Monday, after the up to $1.5 billion buyout of blood cancer-focused Calytrix Bio.
    biospace · 4d ago
  • Isomorphic Labs raises $5B series C months after $2.1B round
    Isomorphic Labs has raised a $5 billion series C round, marking the second time in six months that the AI drug development startup has pulled off a multibillion-dollar financing.
    fiercebiotech · 4d ago
  • Lilly’s early-stage M&A quest finds $1.5B deal for Calytrix’s blood cancer work
    Eli Lilly's business development team has inked 14 buyouts this year so far, with Calytrix Bio tucking into the pharma’s oncology pipeline.
    biospace · 5d ago
view all news mentions →
identifiers
source
globaldata
top tags
Oncology8Type 2 Diabetes4NSCLC3Cardiology2IBD (Crohn's + UC)2
mentioned in
10news items
entity-linker matched
Data sources
openFDA
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?